Bio-Rad's Q4 Revenues Increase 10 Percent on Strong Life Science, Dx Sales | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (Genomeweb News) – Bio-Rad reported after the close of the market Wednesday that its fourth-quarter revenues increased 10 percent with both its life sciences and clinical diagnostics segments contributing double-digit increases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.